Table 1.
Demographic data for the patients in this series (n = 124)
| Readmitted (n = 17) | Not readmitted (n = 107) | |
|---|---|---|
| Gender, n (%) | ||
| Male | 8 (47.1%) | 58 (54.2%) |
| Female | 9 (52.9%) | 49 (45.8%) |
| Race, n (%) | ||
| African American | 1 (5.9%) | 8 (7.5%) |
| White | 16 (94.1%) | 89 (83.2%) |
| Asian American | 0 (0%) | 2 (1.9%) |
| Other | 0 (0%) | 8 (7.5%) |
| Smoking status, n (%) | ||
| Current | 3 (17.6%) | 26 (24.3%) |
| Prior | 7 (41.2%) | 26 (24.3%) |
| Never | 7 (41.2%) | 55 (51.4%) |
| COPD, n (%) | 0 (0%) | 10 (9.4%) |
| Diabetes, n (%) | 4 (23.5%) | 27 (25.2%) |
| Hypertension, n (%) | 10 (58.8%) | 43 (40.2%) |
| Heart disease, n (%) | 2 (11.8%) | 21 (19.6%) |
| Steroid use, n (%) | 0 (0%) | 4 (3.7%) |
| Chronic pancreatitis, n (%) | 9 (52.9%)a | 12 (11.2%) |
| Stent, n (%) | 6 (35.3%) | 45 (42.1%) |
| Transfusion, n (%) | 4 (23.5%) | 26 (24.3%) |
| Whipple type, n (%) | ||
| Pylorus-preserving PD | 0 (0%) | 2 (1.9%) |
| Standard PD | 17 (100%) | 105 (98.1%) |
a
P < 0.05.
COPD, chronic obstructive pulmonary disease; PD, pancreaticoduodenectomy.